diaziquone has been researched along with Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, JS; Khan, AH | 1 |
| Bruntsch, U; Cavalli, F; Høst, H; Joss, R; Pinedo, H; Renard, G; Rozencweig, M; van Glabbeke, M | 1 |
| Ames, MM; Hartmann, LC; Reid, JM; Richardson, RL | 1 |
1 trial(s) available for diaziquone and Melanoma
| Article | Year |
|---|---|
Phase I trial of diaziquone (AZQ) plus GM-CSF.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Blood Platelets; Bone Marrow; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drugs, Investigational; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Melanoma; Neutrophils | 1995 |
2 other study(ies) available for diaziquone and Melanoma
| Article | Year |
|---|---|
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Topics: Animals; Antineoplastic Agents; Aziridines; Brain Neoplasms; Central Nervous System; Ependymoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Quinones | 1976 |
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Blood Cell Count; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Soft Tissue Neoplasms | 1983 |